Adderall is a medicine that doctors use to treat the symptoms of attention deficit hyperactivity disorder (ADHD). Neuropsychiatric disorders are possible in patients of any age, so Adderall can be prescribed to both adults and children.


ADHD is a complex psychological disorder, associated with neurological and behavioral disorders. Children with ADHD may exhibit inattentiveness, difficulty concentrating and poorly managed impulsivity. Adult patients prone to ADHD are forgetful, distracted and disorganized.

Adderall belongs to the first choice drugs - its use for elimination of ADHD symptoms is recommended as the most effective and safe. But Adderall is not able to affect patient's psychological environment. Therefore, treatment course with this drug should be combined with non-drug methods of ADHD treatment:

  • psychotherapy;
  • methods of behavior modification;
  • psychological and pedagogical correction.

Adderall is a potent nervous system stimulant. At first glance, its use seems unreasonable for people, who are already over-active. But in reality, the nervous system stimulation involves neurotransmitters - norepinephrine and dopamine.

Both active components of Adderall, Amphetamine and Dextroamphetamine, increase the release of neurotransmitters:

  • Amphetamine acts both in the central and peripheral nervous system, and promotes the release of noradrenaline.
  • Dextroamphetamine has a predominantly central effect and increases the release of dopamine.

This medication eliminates the imbalance of norepinephrine and dopamine in the brain. Thus, the ADHD psychopharmacotherapy with Adderall is the only method of treatment that affects directly the causes of the disorder.

The result of treatment with Adderall is:

  • decrease of impulsiveness and hyperactivity,
  • improvement of emotions and concentration regulation.

Adderall reaches peak plasma concentrations in 7 hours after the administration. Depending on the patientís age, elimination half-life may las from 9 to 14 hours. Food intake has no influence over the absorption and distribution of Adderall.

Each extended release (ER) Adderall capsule contains 2.5 mg to 7.5 mg of Amphetamine and Dextroamphetamine mixed salts. Optimal therapeutic dose of Adderall should be selected individually for each patient.

The treatment course should start with the minimum effective dose, and the period of Adderall use should be as short as possible:

  • Children with ADHD aged 6 to 12 years can start taking the psychostimulant with a dose of 10 mg per day. The daily dose of the drug may be titrated by 5-10 mg each week. The maximum dose of the psychostimulant for children is 30 mg per day.
  • To alleviate the ADHD symptoms, adolescents aged 13 to 17 years can take 10 mg of Adderall daily. Depending on the tolerability, the daily dose of Adderall can be increased to 20 mgafter a week of regular drug administration.
  • The recommended Adderall dose for adults over the age of 18 is 20 mg daily. The maximum dose of Adderall for the treatment of ADHD in adults is 40mg.

ADHD psychopharmacotherapy with Adderall does not eliminate the disease completely. It helpsto successfully achieve concentration and ignore the distractions. Adderall is one of the most effective stimulants for alleviating the ADHD symptoms.

This drug is a potent tool, and it should be taken with caution. Failure to comply with dosage and recommendations for Adderall use can cause side effects, like heart palpitations, nervousness, dry mouth, or skin rash.

The advantages of Adderall:

  • reduction in ADHD symptoms for the entire day;
  • minimal dosage frequency - once daily;
  • long half-life - up to 14 hours, due to which it acts longer, than other stimulants;
  • no recurrence of hyperactivity and attention disorders after the drug discontinuation.

For the moment, Adderall is the most prescribed drug for alleviating the ADHD symptoms. This psychostimulanthas been used for about 20 years in many countries around the world. A sufficient number of trials in different countries demonstrates the reduction of frequency and intensity of clinical ADHD manifestations in patients on Adderall.